Breaking News Instant updates and real-time market news.

AMGN

Amgen

$176.83

(0.00%)

16:00
12/12/17
12/12
16:00
12/12/17
16:00

Amgen raises quarterly dividend 15% to $1.32 per share

Amgen announced that its Board of Directors declared a $1.32 per share dividend for the first quarter of 2018. The dividend will be paid on March 8, 2018, to all stockholders of record as of the close of business on Feb. 15, 2018. This represents a 15% increase from that paid in each of the previous four quarters.

  • 18

    Jan

  • 03

    Feb

  • 25

    Mar

  • 30

    Apr

  • 17

    May

  • 28

    May

AMGN Amgen
$176.83

(0.00%)

10/31/17
PIPR
10/31/17
NO CHANGE
Target $170
PIPR
Overweight
Piper says Amgen more credible biosimilar threat to Alexion in Europe
Piper Jaffray analyst Christopher Raymond believes Amgen's (AMGN) threat of a biosimilar alternative to Alexion Pharmaceuticals' (ALXN) Soliris may be more credible and near-term than he previously thought. The analyst highlights a Phase 3 study recently listed in the European Union's Clinical Trials Registry, which was authorized in August, as well as evidence of Amgen's active opposition to Alexion's intellectual property extension efforts in Europe. He reminds investors that two-thirds of Soliris' revenue is outside the U.S. Given this new evidence, "it would appear the real battleground may be Europe," Raymond tells investors in a research note. He keeps an Overweight rating on Alexion with a $170 price target. He views the company as well positioned to defend itself against Amgen.
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold from Buy at Argus
11/01/17
ARGS
11/01/17
DOWNGRADE
ARGS
Hold
Amgen downgraded to Hold at Argus on secular slowdown in sales of top drugs
As reported earlier, Argus analyst David Toung downgraded Amgen to Hold from Buy, noting a "secular" slowdown in sales of the company's top three products - Enbrel, Neulasta and Aranesp. Toung says the sales of growth prospects Prolia, Kyprolis and Repatha are not yet large enough to offset the declines in the three established drugs which face generic competition after losing patent protection. The analyst notes that Amgen may not generate commercial revenue from biosimilars until 2019 due to regulatory and legal challenges.
11/29/17
PIPR
11/29/17
NO CHANGE
Target $190
PIPR
Overweight
Piper still bullish on Amgen after management meeting
Piper Jaffray analyst Christopher Raymond says he remains bullish on Amgen shares after hosting the company's management at his firm's healthcare conference. The analyst sees near-term pipeline catalysts from Amgen's immuno-oncology approach, which he sees coming more into focus, Repatha label expansion, Parsabiv launch and Aimovig approval/launch next year. Raymond maintains an Overweight rating on the shares with a $190 price target.

TODAY'S FREE FLY STORIES

BMO

Bank of Montreal

$80.19

0.93 (1.17%)

05:59
10/17/18
10/17
05:59
10/17/18
05:59
Conference/Events
Bank of Montreal to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

TWTR

Twitter

$29.86

1.25 (4.37%)

05:57
10/17/18
10/17
05:57
10/17/18
05:57
Periodicals
Twitter banned 1,500 accounts for misleading election-related content, NYT says »

Over the weekend, Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

TSLA

Tesla

$276.46

16.88 (6.50%)

05:57
10/17/18
10/17
05:57
10/17/18
05:57
Hot Stocks
Tesla's Musk vows to fix 'foolish oversight' in service locations »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 13

    Dec

GOOG

Alphabet

$1,120.11

28.11 (2.57%)

, GOOGL

Alphabet Class A

$1,133.71

32.13 (2.92%)

05:52
10/17/18
10/17
05:52
10/17/18
05:52
Hot Stocks
YouTube resolves widespread access issues also impacgint YouTube TV, Music »

YouTube says it has…

GOOG

Alphabet

$1,120.11

28.11 (2.57%)

GOOGL

Alphabet Class A

$1,133.71

32.13 (2.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

SSNLF

Samsung

$0.00

(0.00%)

05:50
10/17/18
10/17
05:50
10/17/18
05:50
Hot Stocks
Samsung to acquire Zhilabs to expand AI-based automation portfolio »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,818.00

57.01 (3.24%)

05:47
10/17/18
10/17
05:47
10/17/18
05:47
Periodicals
Amazon employee on Medium: Employees asked Bezos to kick Palantir off AWS »

An anonymous Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

LOW

Lowe's

$105.97

1.31 (1.25%)

05:41
10/17/18
10/17
05:41
10/17/18
05:41
Downgrade
Lowe's rating change  »

Lowe's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

HD

Home Depot

$193.61

2.51 (1.31%)

05:40
10/17/18
10/17
05:40
10/17/18
05:40
Downgrade
Home Depot rating change  »

Home Depot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$18.72

0.38 (2.07%)

05:40
10/17/18
10/17
05:40
10/17/18
05:40
Downgrade
U.S. Silica rating change  »

U.S. Silica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVIA

Covia

$7.58

0.18 (2.43%)

05:39
10/17/18
10/17
05:39
10/17/18
05:39
Downgrade
Covia rating change  »

Covia downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SND

Smart Sand

$3.81

-0.07 (-1.80%)

05:39
10/17/18
10/17
05:39
10/17/18
05:39
Downgrade
Smart Sand rating change  »

Smart Sand downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$9.49

-0.16 (-1.66%)

05:38
10/17/18
10/17
05:38
10/17/18
05:38
Downgrade
Hi-Crush Partners rating change  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SCGLY

Societe Generale

$0.00

(0.00%)

, BNPQY

BNP Paribas

$0.00

(0.00%)

05:38
10/17/18
10/17
05:38
10/17/18
05:38
Periodicals
Societe Generale CEO pulls out of Saudi Arabia summit, Reuters reports »

Societe Generale (SCGLY)…

SCGLY

Societe Generale

$0.00

(0.00%)

BNPQY

BNP Paribas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFRY

Safran

$0.00

(0.00%)

05:37
10/17/18
10/17
05:37
10/17/18
05:37
Downgrade
Safran rating change  »

Safran downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

05:36
10/17/18
10/17
05:36
10/17/18
05:36
Periodicals
Uber, Grab fined by Philippine watchdog for rushed merger, Reuters reports »

The Philippine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVPUF

CP All

$0.00

(0.00%)

05:35
10/17/18
10/17
05:35
10/17/18
05:35
Downgrade
CP All rating change  »

CP All downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKPNY

KPN

$0.00

(0.00%)

05:33
10/17/18
10/17
05:33
10/17/18
05:33
Upgrade
KPN rating change  »

KPN upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGR

Eiger BioPharmaceuticals

$10.88

0.63 (6.15%)

05:32
10/17/18
10/17
05:32
10/17/18
05:32
Recommendations
Eiger BioPharmaceuticals analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ALTR

Altair

$35.24

1.14 (3.34%)

05:29
10/17/18
10/17
05:29
10/17/18
05:29
Hot Stocks
Altair announces acquisition of SIMSOLID »

Altair has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

  • 16

    Nov

ARWR

Arrowhead

$13.86

0.71 (5.40%)

05:27
10/17/18
10/17
05:27
10/17/18
05:27
Recommendations
Arrowhead analyst commentary  »

Arrowhead 25% pullback a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

UTX

United Technologies

$132.50

2.18 (1.67%)

05:27
10/17/18
10/17
05:27
10/17/18
05:27
Recommendations
United Technologies analyst commentary  »

UTC Aerospace Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UTX

United Technologies

$132.50

2.18 (1.67%)

05:25
10/17/18
10/17
05:25
10/17/18
05:25
Hot Stocks
Royal Dutch Touring Club ANWB selects Pratt & Whitney for EMS fleet renewal »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$338.26

9.52 (2.90%)

05:24
10/17/18
10/17
05:24
10/17/18
05:24
Hot Stocks
Biogen announces European launch of Imraldi »

Samsung Bioepis, a joint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

NFLX

Netflix

$346.40

13.29 (3.99%)

05:23
10/17/18
10/17
05:23
10/17/18
05:23
Recommendations
Piper says Netflix is back on track, boosts price target to $430 »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

IQ

iQIYI

$25.91

-0.19 (-0.73%)

, VIA

Viacom

$36.07

1.11 (3.18%)

05:22
10/17/18
10/17
05:22
10/17/18
05:22
Hot Stocks
iQIYI signs international distribution agreement with Viacom »

iQIYI (IQ ) announced it…

IQ

iQIYI

$25.91

-0.19 (-0.73%)

VIA

Viacom

$36.07

1.11 (3.18%)

VIAB

Viacom

$32.83

1.05 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.